ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE IIIA BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE IIIA BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE IIIA BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made vaccine takes on tough breast cancer
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage trial tests a personalized vaccine made from a patient's own tumor, combined with drugs that boost the immune system (pembrolizumab or ipilimumab), for triple negative breast cancer. The goal is to see if the vaccine is safe and can help the immune system attack …
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: Emory University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 08, 2026 13:08 UTC
-
BREAST CANCER BREAKTHROUGH: thousands could avoid unnecessary treatment
Disease control Recruiting nowThis study is for people with early-stage triple-negative breast cancer whose tumors completely disappeared after initial chemotherapy plus immunotherapy (pembrolizumab). It compares the usual approach of continuing pembrolizumab for 27 more weeks versus simply watching and waiti…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 16, 2026 12:54 UTC
-
New study may spare some breast cancer patients from chemotherapy
Disease control Recruiting nowThis study tests whether hormone therapy plus a targeted drug (ribociclib) works as well as chemotherapy followed by the same hormone therapy for people with high-stage, estrogen-positive, HER2-negative breast cancer that has a low risk of coming back. About 1,978 postmenopausal …
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
Custom-Made vaccine plus immunotherapy shows promise for advanced cancers
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, given alone or with the immunotherapy drug pembrolizumab, for people with advanced solid tumors (like breast, lung, or skin cancer). The goal is to see if the combination is safe and helps control t…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Could a shorter, safer chemo work just as well for aggressive breast cancer?
Disease control Recruiting nowThis study tests if a shorter chemotherapy regimen without a strong drug called anthracycline, combined with immunotherapy, works as well as the standard longer treatment for early-stage triple-negative breast cancer. About 2,400 people will receive either the shorter or standard…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 15, 2026 19:01 UTC
-
New drug combo shows promise in shrinking tough breast cancer before surgery
Disease control Recruiting nowThis study tests whether adding the drug darolutamide to standard chemotherapy and immunotherapy before surgery can shrink tumors more effectively in people with early-stage androgen receptor positive triple-negative breast cancer. About 51 participants will receive either standa…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Vandana Abramson • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Electric field device joins forces with cancer drugs in early trial
Disease control Recruiting nowThis early-phase study tests a wearable device that creates electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The goal is to find …
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC
-
New combo therapy aims to outsmart drug resistance in hereditary breast cancer
Disease control Recruiting nowThis study tests whether adding cediranib or AZD6738 to olaparib can overcome resistance in people with advanced or metastatic breast cancer who have a BRCA gene mutation. About 60 participants will receive one of the combination treatments. The goal is to see if these combos can…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 03, 2026 12:02 UTC
-
Can a baldness drug save hair during breast cancer treatment?
Symptom relief Recruiting nowThis study looks at whether minoxidil (a hair growth drug) can help with hair loss caused by hormone therapy in breast cancer patients. About 50 women with stage I-IV breast cancer who are on hormone therapy and have noticed hair thinning will either take minoxidil pills or apply…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 16, 2026 12:55 UTC
-
Laser therapy offers hope for breast cancer survivors suffering from vaginal dryness
Symptom relief Recruiting nowThis study tests a laser treatment for vaginal dryness in breast cancer survivors. Many survivors experience this side effect from cancer treatments like chemotherapy or hormone therapy. The trial will compare the laser to no treatment in 250 women to see if it improves symptoms.
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Symptom relief
Last updated Jun 15, 2026 18:57 UTC
-
Exercise boosts brain power in breast cancer survivors, new study finds
Symptom relief Recruiting nowThis study tests if a community exercise program can improve memory, attention, and brain health in breast cancer survivors. Researchers will compare exercise to health education in 160 women aged 50+ who finished treatment 3-36 months ago. The goal is to find a safe, accessible …
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 11, 2026 11:57 UTC
-
CBD trial aims to keep breast cancer patients Pain-Free on hormone pills
Symptom relief Recruiting nowThis study tests a high-CBD plant extract (BRC-001) to see if it reduces joint pain and stiffness in women with breast cancer who take aromatase inhibitors (AIs). AIs lower estrogen to prevent cancer return but often cause arthritis-like side effects, leading some women to stop t…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 10, 2026 13:25 UTC
-
Can your social life help you beat Cancer's aftermath? new study investigates
Knowledge-focused Recruiting nowThis study looks at how personal relationships and physical activity influence the quality of life of young adults (ages 18-39) who have been diagnosed with cancer. Researchers will track 250 participants over time to see how social connections and exercise habits change and affe…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:52 UTC
-
New tool aims to help women with breast cancer make tough surgery choices
Knowledge-focused Recruiting nowThis study looks at whether a decision-making tool helps women newly diagnosed with early-stage breast cancer decide if they want preventive mastectomy on their healthy breast. About 15 participants will use the tool and rate how clear and balanced it is. The goal is to see if th…
Matched conditions: ANATOMIC STAGE IIIA BREAST CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 01, 2026 18:08 UTC